AzTrials
AzTrials

Autism Spectrum Disorder (ASD)NCT06924008

Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism

An observational study of Autism Spectrum Disorder (ASD) and Relative (Related Person), run by UMC Utrecht at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to develop a methodological intervention for adults with autism that will help them reduce problems arising from eye contact. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
How many people
18 participants
Where
1 siteNetherlands
Study dates
7 Jul 2025to 2 Nov 2026
How long will I take part?
6 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population consists of adults with autism, caregivers of adults with autism, and healthcare providers (psychiatrists, psychologists and nursing specialists in psychiatry).

Who may be able to join

  • Adults classified with autism, determined according to an internationally recognized classification system.
  • Outpatient treatment within a specialized autism center in the Netherlands.
  • Able to understand the topics to be discussed.
  • Motivation to participate in research.
  • Adults without DSM classification.
  • Living in the Netherlands.
Show all 11Show fewer
  • Able to understand the topics to be discussed.
  • Motivation to participate in research.
  • Practicing psychiatrist, clinical psychologist or nurse specialist at an autism expertise center in the Netherlands.
  • Living in the Netherlands.
  • Motivation to participate in research.

Who cannot join

  • No good command of the Dutch language.
  • Use of alcohol and/or recreational drugs during the study.
  • Mentally too unstable to participate in the study.
  • Familiarity with treatment in the VGZ.
  • No good command of the Dutch language.
  • Use of alcohol and/or recreational drugs during the study.
  • No good command of the Dutch language.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nynke Boonstra, Professor contact

tboonst2@umcutrecht.nl

Netherlands1 site, 1 recruiting
  • Dimence Groep

    Deventer, Overijssel, 7416 SB

    Nynke Boonstra, Professor, +31 6 22678011, tboonst2@umcutrecht.nl

    Bram Sizoo, Professor, b.b.sizoo@uva.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Development of an Intervention Aimed at Facilitating the Use of Eye Contact in Adults With Autism: A Qualitative Study With Methodological Triangulation

The aim of this study is to develop a methodological intervention for adults with autism that will help them reduce problems arising from eye contact.

Read the detailed description

Eye contact is fundamental to human interaction, not only in terms of the experience of connection with others, but also in terms of cognitive skills and social-emotional development. In adults with autism, eye contact is sometimes atypical, which in individual cases can lead to problems in the aforementioned areas. An intervention could possibly lead to a reduction of these problems. However, to date, there is no insight into the problems that this population experiences due to eye contact, how this differs from people without autism, to what extent adults with autism wish to optimize eye contact with others, what they themselves see as solutions for this, and when it proves fruitful to develop an intervention based on all these facets; what an effective intervention could be for this (and who the target group is). While insight into all of this could lead to a reduction in problems that adults with autism and/or their interaction partner experience due to their eye contact. To gain this insight, it is necessary to inventory, among both adults with and without autism, what problems adults with autism actually experience with regard to eye contact, and what their ideas are to reduce these problems. In addition, it is necessary to investigate in a substantiated methodical way which intervention forms a solution for the distilled problems and to test these, in order to be able to assess their effectiveness. If effective, then this intervention could at least contribute to the well-being of adults with autism and a mutually pleasant contact with interaction partners. The current study aims to provide for this and to arrive at an effective intervention that will help adults with autism experience less difficulty as a result of eye contact.

The research design chosen is qualitative research using triangulation by means of descriptive research in the form of semi-structured interviews and Intervention Mapping. The interviews have now taken place. These interviews, in addition to available scientific literature on eye contact in adults with autism, form the starting point for intervention development by means of Intervention Mapping. Intervention Mapping was chosen because the goal is to develop an intervention that will later be as effective as possible. This can be achieved by carefully weighing and substantiating the choices for the goal and the approach in the design phase. Intervention Mapping provides a theoretical basis for the intervention, which makes it more likely that the intervention will also work in practice. In addition, it provides a systematically described intervention and an implementation plan, making the intervention transferable and easier to put into practice. A major advantage of Intervention Mapping is that attention is paid to the way in which the results and effects of the project should be evaluated later, already in the development phase. In this way, Intervention Mapping contributes to increasing the effectiveness of the project. The aim of Intervention Mapping is to provide a framework for effective decision-making at every step of planning, implementation and evaluation. The Intervention Mapping protocol consists of six steps, with a number of tasks described for each step. Although Intervention Mapping is presented as a series of steps, it can be seen as iterative rather than linear. Programme planners switch back and forth between tasks and steps. The process is also cumulative: each step is based on previous steps.

Keywords
Intervention, Eye contact, Autism Spectrum Disorder, ASD, Intervention Mapping
Medical subject headings
Autism Spectrum Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Developing an intervention using the Intervention Mapping method.

    An effective intervention for adults with autism that reduces their difficulty with eye contact problems, with use of Intervention Mapping.

    The Intervention Mapping protocol consists of six steps, with a number of tasks described for each step. These steps are carried out within focus groups, with two months of time set aside for each step.

    The six steps of the Intervention Mapping process are:

    Step 1: Needs assessment Step 2: Change objectives Step 3: Theoretical methods and practical techniques Step 4: Programme design and production Step 5: Program Adoption and Implementation Step 6: Evaluation

    Measured: Up to 12 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2025
  2. Study start7 Jul 2025 (estimated)
  3. Primary completion3 Jul 2026 (estimated)
  4. Study completion2 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
18 participants (estimated)
Target duration
6 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT06924008
Sponsor's protocol ID
559903
Other IDs
Dimence Groep
Status last verified
Apr 2025
First submitted
28 Mar 2025
Last updated
11 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder (ASD) and Relative (Related Person), run by UMC Utrecht at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jos Boer, MSc (+31 6 20083507, j.c.boer-30@umcutrecht.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Developing an intervention using the Intervention Mapping method. (time frame: Up to 12 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in